-+ 0.00%
-+ 0.00%
-+ 0.00%

POLYRIZON SUBMITS PRE-REQUEST FOR DESIGNATION TO FDA FOR PL-16 VIRAL BLOCKER DESIGNED TO REDUCE THE EXPOSURE TO INFLUENZA AND COLD VIRUSES

Reuters·12/19/2025 13:20:00

Please log in to view news